Reconstitution of hepatitis C virus-specific T-cell - Mediated immunity after liver transplantation

Hepatology

Volumn 41, Issue 1, 2005, Pages 72-81

  Weston, Scott J ^a,c   Leistikow, Rachel L ^a,c   Reddy, K Rajender ^a,d   Torres, Maria ^a,e   Wertheimer, Anne M ^a,c   Lewinsohn, David M ^a,c   Chou, Sunwen ^a,c   Davey, Michael P ^a   Corless, Christopher ^b,c   O'Farrelly, Cliona ^f   Nelson, David R ^a,g   Rosen, Hugo R ^a,c  

^a Department of Medicine ^*  (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^g UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHORBOL 13 ACETATE 12 MYRISTATE; RAPAMYCIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TACROLIMUS; TETRAMER;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT INFECTION; T LYMPHOCYTE; VIRUS REPLICATION;

ADULT; AGED; ANTIBODY FORMATION; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNITY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PHENOTYPE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RECURRENCE; T-LYMPHOCYTES;

EID: 19944428195     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20507     Document Type: Article

References (32)

1. Rehermann B, Chisari FV. Cell mediated immune response to the hepatitis C virus. Curr Top Microbiol Immunol 2000;242:299-325.
2. Laurence J. Potential roles for chemokine receptor CCR5 in the pathobiology of hepatitis C infection. Gastroenterology 2002;122:2069-2071.
3. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dobrenwend P, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000;191:1499-1512.
4. Freeman AJ, Pan Y, Harvey CE, Post JJ, Law MG, White PA, Rawlinson WD, Lloyd AR, Marinos G, Ffrench RA. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J Hepatol. 2003 Mar;38(3):349-56.
5. Bassett SE, Brasky KM, Lanford RE. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profile. J Virol 1998;72:2589-2599.
6. Rosen HR, Martin P. Viral hepatitis in the liver transplant recipient. Infect Dis Clin North Am 2000;3:761-784.
7. Garcia-Retortillo M, Forns X, Feliu A, Moitinho E, Costa J, Navasa M, et al. Hepatitis C virus kinetics during and immediately after liver transplantation. HEPATOLOGY 2002;35:680-687.
8. Gane EJ, Portmann BC, Naoumouv NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Eng J Med 1996;334:821-827.
9. Rosen HR, Hinrichs DJ, Gretch DR, Koziel MJ, Chou S, Houghton M, et al. Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 1999;117:926-932 (comments, p 1012-1014).
10. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C. Gastroenterology 1999;117:933-941.
11. Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Surg Pathol 1995;19:1409-1417.
12. Wertheimer AW, Miner C, Lewinsohn DM, Sasaki AW, Kaufman E, Rosen HR. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. HEPATOLOGY 2003;37:577-589.
13. Rosen HR, Marousek G, Chou S. A longitudinal analysis of T-cell epitope coding regions of hepatitis C virus following liver transplantation. Transplantation 2002;27;74:209-216.
14. Gopal DV, Rosen HR. Duration of combination antiviral therapy for cholestatic HCV recurrence may need to be indefinite. Liver Transplantation 2003;9:348-353.
15. McCaughan GW, Zekry A. Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transpl 2002;8(10 Suppl 1):S7-S13.
16. Yee C, Riddell SR, Greenberg PD. In vivo tracking of tumor-specific T cells. Curr Opin Immunol 2001;13:141-144.
17. He XS, Rehermann B, Lopez-Labrador FX, Boisvert J, Cheung R, Mumm J, et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A. 1999;96:5692-5697.
18. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memor T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-713.
19. Lucas M, Vargas-Cuero AL, Lauer GM, Barnes E, Willberg CB, Semmo N, Walker BD, Phillips R, Klenerman P. Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells. J Immunol. 2004 Feb 1;172:1744-53.
20. Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, Rice CM, et al. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 2003;77:4781-4793.
21. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol. 2001;75:5550-5558.
22. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol. 2002;169:3447-3458.
23. Rosen HR. Hepatitis C virus in the human liver transplantation model. Clin Liver Dis 2003;7:107-125.
24. Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, et al. Genomic analysis of the host response to hepatitis C virus infection. PNAS 1999;24:15669-15674.
25. Guidotti L, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996;4:25-31.
26. Frese M, Schwatzle V, Barth K, Krieger N, Lohmann V, Mihm S, et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. HEPATOLOGY 2002;35:694-703.
27. Liu C, Zhu H, Tu Z, Xu YL, Nelson DR. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity. HEPATOLOGY 2003;37:1335-1342.
28. Schirren CA, M-C Jung, Worzfeld T, Mamin M, Baretton G, Gerlach JT, Gruener NH, et al. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver and does not correlate with recurrent disease. J of Infectious Diseases 2001;183:1187-94.
29. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. HEPATOLOGY 2000;32:1125-1130.
30. Schirren CA, Zachoval R, Gerlach JT, Ulsenheimer A, Gruener NH, Diepolder HM, et al. Antiviral treatment of recurrent hepatitis C infection after liver transplantation: association with a strong, multispecific, and long-lasting CD4+ T cell response with HCV elimination. J Hepatol 2003;397-404.
31. Lauer G, Ouchi K, Chung RT, Nguyen TN, Day CL, Purkis DR, et al. Comprehensive analysis of CD8+ T cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 2002;76:6103-6113.
32. Gane E. Treatment of recurrent hepatitis C. Liver Transpl 2002;8(10 Suppl 1):S28-S37.